Successful treatment of malignant placental site trophoblastic tumor with combined cytostatic-surgical approach: Case report and review of literature

Gynecologic Oncology

Volumn 75, Issue 1, 1999, Pages 164-169

  Janni, W ^a   Hantschmann, P ^a   Rehbock, J ^a   Braun, S ^a   Lochmueller, E ^a   Kindermann, G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Gestational trophoblastic disease; Multiagent chemotherapy; Placental site trophoblastic tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PLACENTA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SURGICAL APPROACH; TROPHOBLAST; TROPHOBLASTIC TUMOR; VAGINAL DELIVERY;

EID: 0032871735     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5550     Document Type: Article

References (43)

1. Horn L C, Bilek K. Histologic classification and staging of gestational trophoblastic disease. Gen Diagn Pathol. 143:1997;87-101.
2. Berkowitz R S, Goldstein D P. Chorionic tumors. N Engl J Med. 335:1996;1740-1748.
3. Berkowitz R S, Goldstein D P. Recent advances in gestational trophoblastic disease. Curr Opin Obstet Gynecol. 10:1998;61-64.
4. Kurman R J, Scully R E, Norris H J. Trophoblastic pseudotumor of the uterus: an exaggerated form of "syncytial endometritis" simulating a malignant tumor. Cancer. 38:1976;1214-1226.
5. Twiggs L B, Okagaki T, Phillips G L, Stroemer J R, Adcock L L. Trophoblastic pseudotumor - evidence of malignant disease potential. Gynecol Oncol. 12:1981;238-248.
6. Scully R E, Young R H. Trophoblastic pseudotumor: a reappraisal. Am J Surg Pathol. 5:1981;75-76.
7. Denny L A, Dehaeck K, Nevin J, Soeters R, van-Wijk A L, Megevand E, Bloch B. Placental site trophoblastic tumor: three case reports and literature review. Gynecol Oncol. 59:1995;300-303.
8. Lathrop J C, Lauchlan S, Nayak R, Ambler M. Clinical characteristics of placental site trophoblastic tumor (PSTT). Gynecol Oncol. 31:1988;32-42.
9. How J, Scurry J, Grant P, Sapountzis K, Ostor A, Fortune D, Armes J. Placental site trophoblastic tumor. Report of three cases and review of the literature. Int J Gynecol Cancer. 5:1995;241-249.
10. Swisher E, Drescher C W. Metastatic placental site trophoblastic tumor: long-term remission in a patient treated with EMA/CO chemotherapy. Gynecol Oncol. 68:1998;62-65.
11. Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, Passlick B, Izbicki J R, Riethmuller G. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother. 3:1994;165-173.
12. Vardar M A, Altintas A. Placental-site trophoblastic tumor. Principles of diagnosis, clinical behaviour and treatment. Eur J Gynaecol Oncol. 16:1995;290-295.
13. Redline R W, Abdul K F. Pathology of gestational trophoblastic disease. Semin Oncol. 22:1995;96-108.
14. Fisher R A, Paradinas F J, Newlands E S, Boxer G M. Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. Br J Cancer. 65:1992;355-358.
15. McLellan R, Buscema J, Currie J L, Woodruff J D. Placental site trophoblastic tumor in a postmenopausal woman. Am J Clin Pathol. 95:1991;670-675.
16. Swoboda M, Nagl F, Brinninger G, Breitenecker G, Danihel L. Placental site trophoblastic tumour appearing three years after menopause (Placental Site Trophoblastic Tumor Drei Jahre nach der Menopause). Geburtsh Frauenheilk. 1997;46-49.
17. Young R H, Scully R E, McCluskey R T. A distinctive glomerular lesion complicating placental site trophoblastic tumor: report of two cases. Hum Pathol. 16:1985;35-42.
18. Dessau R, Rustin G JS, Dent J, Paradinas F J, Bagshawe K D. Surgery and chemotherapy in the management of placental site tumor. Gynecol Oncol. 39:1990;56-59.
19. Bagshawe K D. Risk and prognostic factors in trophoblastic neoplasia. Cancer. 38:1976;1373-1385.
20. Goldstein D P, Zanten P IV, Bernstein M R, Berkowitz R S. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. J Reprod Med. 43:1998;37-43.
21. Bower M, Newlands E S, Holden L, Short D, Brock C, Rustin G J, Begent R H, Bagshawe K D. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients [published erratum appears in J Clin Oncol 15(9):3168, 1997]. J Clin Oncol. 15:1997;2636-2643.
22. Heintz A P, Schaberg A, Engelsman E, van-Hall E V. Placental-site trophoblastic tumor: diagnosis, treatment, and biological behavior. Int J Gynecol Pathol. 4:1985;75-82.
23. Larsen L G, Theilade K, Skibsted L, Jacobsen G K. Malignant placental site trophoblastic tumor. A case report and a review of the literature. APMIS Suppl. 23:1991;138-145.
24. Hopkins M, Nunez C, Murphy J R, Wentz W B. Malignant placental site trophoblastic tumor. Obstet Gynecol. 66:1985;95S-100S.
25. Finkler N J, Berkowitz R S, Driscoll S G, Goldstein D P, Bernstein M R. Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center. Obstet Gynecol. 71:1988;854-857.
26. Wain G V, Friedlander M L, Jensen D, Truskett P. Placental site trophoblast tumor (PSTT) - an enigmatic disease: two case reports. Int J Gynecol Cancer. 3:1993;47.
27. Eckstein R P, Russell P, Friedlander M L, Tattersall M H, Bradfield A. Metastasizing placental site trophoblastic tumor: a case study. Hum Pathol. 16:1985;632-636.
28. Hopkins M P, Drescher C W, McQuillan A, Keyser J, Schmidt R. Malignant placental site trophoblastic tumor associated with placental abruption, fetal distress, and elevated CA-125. Gynecol Oncol. 47:1992;267-271.
29. Samlowski W E, Abbott T M, Kepas D E, Eyre H J. Placental-site trophoblastic tumor (trophoblastic pseudotumor): case report demonstrating failure of chemotherapy, surgery, and radiotherapy to control metastatic disease. Gynecol Oncol. 21:1985;111-117.
30. Hammond C B, Borchert L G, Tyrey L, Creasman W T, Parker R T. Treatment of metastatic trophoblastic disease: good and poor prognosis. Am J Obstet Gynecol. 115:1973;451-477.
31. Lurain J R. Management of high-risk gestational trophoblastic disease. J Reprod Med. 43:1998;44-52.
32. Schink J C, Singh D K, Rademaker A W, Miller D S, Lurain J R. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease. Obstet Gynecol. 80:1992;817-820.
33. Biran H, Dgani R, Wasserman J P, Weissberg D, Shani A. Pneumothorax following induction chemotherapy in patients with lung metastases: a case report and literature review. Ann Oncol. 3:1992;297-300.
34. Hartenbach E M, Saltzman A K, Carter J R, Twiggs L B. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease. Gynecol Oncol. 56:1995;105-108.
35. Kodama S, Kase H, Aoki Y, Yahata T, Tanaka K, Motoyama T, Dewa K. Recurrent placental site trophoblastic tumor of the uterus: clinical, pathologic, ultrastructural, and DNA fingerprint study. Gynecol Oncol. 60:1996;89-93.
36. Soper J T. Identification and management of high-risk gestational trophoblastic disease. Semin Oncol. 22:1995;172-184.
37. Mutch D G, Soper J T, Babcock C J, Clarke P D, Hammond C B. Recurrent gestational trophoblastic disease. Cancer. 66:1990;978-982.
38. Seckl M J, Newlands E S. Treatment of gestational trophoblastic disease. Gen Diagn Pathol. 143:1997;159-171.
39. Newlands, E, S, Seckl, M, J, Holden, L, Rustin, G, JS, Results and toxicity using the EP (etoposide, cisplatinum)/EMA (etoposide, methotrexate, actinomycin D) schedule in patients with gestational trophoblastic tumors (GTT). Proc ASCO 35th Annual Meeting, 1999, (Abstract).
40. Newlands, E, S, Seckl, M, J, Holden, L, Rustin, G, JS, Results and toxicity using the EP (etoposide, cisplatin)/EMA (etoposide, methotrexate, actinomycin D) schedule in patients with gestational trophoblastic tumours (GTT). IXth World Congress for Gestational Trophoblastic Disease, International Society for the Study of Trophoblast, Jerusalem, 10-11-1998 (Conference Proceeding).
41. Giacalone P L, Benos P, Donnadio D, Laffargue F. High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease. Gynecol Oncol. 58:1995;383-385.
42. Newlands E S, Bagshawe K D, Begent R H, Rustin G J, Holden L. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol. 98:1991;550-557.
43. Soper J T, Evans A C, Clarke P D, Berchuck A, Rodriguez G, Hammond C B. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol. 83:1994;113-117.